Re:Wall Street Teacher
I’m sure he’s just having some fun with the topic. Obviously we all know that the FDA wouldn’t permit a person, much less a child, even one suffering with extremely low survival rates to be treated if the company didn’t first go through the full and lengthy authorization process. That said, the CEO ran out of his grace period long ago and very much needs to demonstrate he can get a meaningful treatment to the finish line. The bottom line it’s all about pay for performance and he needs results if he hopes to keep his job beyond this year.